Volume: 43 Issue: 3
Year: 2023, Page: 808-815, Doi: https://doi.org/10.51248/.v43i3.2678
Platelet-rich plasma therapy, also truncated as PRP, has been remarkably utilized for quite long in the domains of cardiovascular surgery, orthopaedic treatments, sports medicines etc. Being in the limelight for its remarkable wound healing and cell proliferating activities, it has caught the interest of researchers in the field of reproductive sciences. The chief domain of research has revolved around thin endometrial lining, diminished ovarian content, recurrent implantation failure ailments etc. This article has focused on reviewing existing articles till now on the aetiology of PRP along with methodologies and results in reproductive aberrational conditions. Restrictive research is conducted from Scopus and Web of Science indexed journals, PubMed focusing on the deployment of PRP in infertility science and categorized the result under 3 genres: PRP in refractory attenuated endometrium, PRP in female gonadal abnormalities and PRP in Asherman’s syndrome. Most literature has shown promising results in improvement of thin endometrium, along with increase in AMH (Anti-Mullerian Hormone) level along with decrement of FSH (Follicle Stimulating Hormone) level, thereby improving ovarian reserve. It also showed reduced adhesion in the uterus after hysteroscopy, along with improvement in the menstrual cycle in case of Asherman’s syndrome, thereby increasing chances of clinical pregnancy. However, lack of standardized protocol is a major con in variation of results. Thus, until conclusive RCTs with larger sample size are conducted, PRP should be restricted to the experimental stage for now.
Keywords: Thin endometrium; Asherman’s syndrome; diminished ovarian reserve; FSH; clinical pregnancy
1. Vander Borght, M., Wyns, C. Fertility and infertility: Definition and epidemiology. Clin. Biochem. 2018; 62: 2-10.
2. Hajipour, H., Farzadi, L., Latifi, Z., Keyhanvar, N., Navali, N., Fattahi, A., et al., An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects. Systems Biology in Reproductive Medicine; 67(3):177-188.
3. Sharara, F.I., Lelea, L.L., Rahman, S., Klebanoff, J.S., Moawad, G.N. A narrative review of platelet-rich plasma (PRP) in reproductive medicine. Journal of Assisted Reproduction and Genetics. 2021; 38(5):1003-1012.
4. Sukmawati, D., Junaidi, H., Syaidah, R. Human platelet-rich plasma as a biological stimulant for proliferation and differentiation of mesenchymal stem cells. Biomedicine. 2021 Jul 7;41(2):168-173.
5. Pavlovic, V., Ciric, M., Jovanovic, V., Stojanovic, P. Platelet Rich Plasma: a short overview of certain bioactive components. Open Med. 2016; 11(1):242-247.
6. Ezzatt, O.M. Autologous Platelet Concentrate Preparations in Dentistry. Biomedical Journal of Scientific & Technical Research. 2018; 8(5).
7. Lansdown, D.A., Fortier, L.A. Platelet-Rich Plasma: Formulations, Preparations, Constituents, and Their Effects. Operative Technique in Sports Medicine. 2017; 25(1):7-12.
8. Rajendran, S., Thiyagarajan, M., Singh, B., Navrathan, N. A comparative study on effect of platelet rich plasma Vs conventional dressing in healing rate of chronic diabetic ulcers. Biomedicine. 2021 Dec 31;41(4):849-854.
9. Karina, K., Ekaputri, K., Biben, J. A., Rosadi, I., Rosliana, I., Sobariah, S., et al., Evaluation of plasma PDGF and VEGF levels after systemic administration of activated autologous platelet-rich plasma. Biomedicine. 2021 Sep 7;41(2):409-412.
10. Alves, R., Grimalt, R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disorders. 2018;4(1):18-24.
11. Dogra, Y., Singh, N., Vanamail, P. Autologous platelet-rich plasma optimizes endometrial thickness and pregnancy outcomes in women with refractory thin endometrium of varied aetiology during fresh and frozen-thawed embryo transfer cycles. JBRA Assist Reprod. 2022;26(1):13-21.
12. Tandulwadkar, S., Naralkar, M., Surana, A., Selvakarthick, M., Kharat, A. Autologous intrauterine platelet-rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: A pilot study. J Hum Reprod Sci. 2017;10(3):208-212.
13. Chang, Y., Li, J., Wei, L. N., Pang, J., Chen, J., Liang, X. Autologous platelet-rich plasma infusion improves clinical pregnancy rate in frozen embryo transfer cycles for women with thin endometrium. Medicine (Baltimore). 2019; 98(3): e14062.
14. Gomes de Melo, B.A., Malheiros Luzo, A.C., Duarte Lana, J.F.S., Andrade Santana, M.H. Centrifugation conditions in
the L-PRP Preparation affect soluble factors release and mesenchymal stem cell proliferation in fibrin nanofibers. Molecules. 2019; 27; 24(15):27-29.
15. Kemmochi, M. Consecutive injections of leukocyte-rich platelet-rich plasma are effective in not only mild but also severe knee degeneration. J Orthop. 2022; 29:31-37.
16. Godoi, T.T.T., Rodrigues, B.L., Huber, S.C., Santana, M.H.A., Da Fonseca, L.L.F., Santos, G.S., et al., Platelet-rich plasma gel matrix (PRP-GM): Description of a new technique. Bioengineering. 2022; 9(12):817.
17. El, Bagdadi, K., Kubesch, A., Yu, X., Al-Maawi, S., Orlowska, A., Dias, A., et al., Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept). Eur J Trauma Emerg Surg. 2019; 45(3):467-479.
18. Miron, R.J., Chai, J., Fujioka-Kobayashi, M., Sculean, A., Zhang, Y. Evaluation of 24 protocols for the production of platelet-rich fibrin. BMC Oral Health. 2020; 20(1):310.
19. Chang, Y., Li, J., Chen, Y., Wei, L., Yang, X., Shi, Y., et al., Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015; 8(1):1286-1290.
20. Nazari, L., Salehpour, S., Hosseini, S., Sheibani, S., Hosseinirad, H. The effects of autologous platelet-rich plasma on pregnancy outcomes in repeated implantation failure patients undergoing frozen embryo transfer: A Randomized controlled trial. Reprod Sci. 2022; 29(3): 993-1000.
21. Kim, H., Shin, J. E., Koo, H.S., Kwon, H., Choi, D.H., Kim, J.H., et al., Effect of autologous platelet-rich plasma treatment on refractory thin endometrium during the frozen embryo transfer cycle: A pilot study. Front Endocrinol. 2019; 10:61.
22. Russell, S. J., Kwok, Y.S.S., Nguyen, T.T.T.N., Librach, C. Autologous platelet-rich plasma improves the endometrial thickness and live birth rate in patients with recurrent implantation failure and thin endometrium. J Assist Reprod Genet. 2022; 39(6):1305-1312.
23. Efendieva, Z., Vishnyakova, P., Apolikhina, I., Artemova, D., Butov, K., Kalinina, E., et al., Hysteroscopic injections of autologous endometrial cells and platelet-rich plasma in patients with thin endometrium: a pilot randomized study. Sci Rep. 2023;13(1):945.
24. Zadehmodarres, S., Salehpour, S., Saharkhiz, N., Nazari, L. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod. 2017;21(1):54-56.
25. Eftekhar, M., Neghab, N., Naghshineh, E., Khani, P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol. 2018; 57(6):810-813.
26. Agarwal, M., Mettler, L., Jain, S., Meshram, S., Günther, V., Alkatout, I., et al., Management of a thin endometrium by hysteroscopic instillation of platelet-rich plasma into the endomyometrial junction: A Pilot Study. J Clin Med. 2020; 9(9):2795.
27. Sills, E. S., Rickers, N. S., Li, X., Palermo, G.D. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2018 Sep; 34(9):756-760.
28. Pantos, K., Simopoulou, M., Pantou, A., Rapani, A., Tsioulou, P., Nitsos, N., et al., A case series on natural conceptions resulting in ongoing pregnancies in menopausal and prematurely menopausal women following platelet-rich plasma treatment. cell transplant. 2019; 28(9-10):1333-1340.
29. Farimani, M., Heshmati, S., Poorolajal, J., Bahmanzadeh, M. A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP). Mol Biol Rep. 2019;46(2):1611-1616.
30. Farimani, M., Nazari, A., Mohammadi, S., Aliabad, A.R. Evaluation of intra-ovarian platelet-rich plasma
administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria. Reprod Biol Endocrinol. 2021;19(1):137. Erratum in: Reprod Biol Endocrinol. 2021; 19(1):169.
31. Hsu, C.C., Hsu, L., Hsu, I., Chiu, Y. J., Dorjee, S. Live birth in woman with premature ovarian insufficiency receiving ovarian administration of platelet-rich plasma (PRP) in combination with gonadotropin: A case report. Front Endocrinol. 2020;11:50.
32. Parikh, F.R., Sawkar, S.G., Agarwal, S., Makwana, P.P., Khandeparkar, K.M.S., Naik, N.J., et al., A novel method of intraovarian instillation of platelet rich plasma to improve reproductive outcome in young Indian women with diminished ovarian reserve. Glob Reprod Health. 2022;7(2): e59-e59.
33. Rezk, M., Moustafa, M., Abd-Rabboh, H., Ibrahim, M. Effect of intraovarian injection of autologous platelet rich plasma (PRP) in premature ovarian insufficiency. Al-Azhar Int Med J. 2022; 3(7): 128-133.
34. Hosseinisadat, R., Farsi, N. A., Mohammadi, F. Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study. Eur J Obstet Gynecol Reprod Biol. 2023; 280:60-63.
35. Sfakianoudis, K., Simopoulou, M., Nitsos, N., Rapani, A., Pantou, A., Vaxevanoglou, T., et al., A case series on platelet-rich plasma revolutionary management of poor responder patients. Gynecol Obstet Invest. 2019;84(1):99-106.
36. Parvanov, D., Ganeva, R., Vidolova, N., Nikolova, K., Vasileva, M., Totev, T., et al., Autologous ovarian platelet rich plasma treatment improves oocyte and embryo quality: a before-after prospective study. Biotechnol Biotechnol Equip. 2022;36(1):425-432.
37. Merhi, Z., Seckin, S., Mouanness, M. Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization. Clin Exp Reprod Med. 2022;49(3):210-214.
38. Aghajanova, L., Houshdaran, S., Balayan, S., Manvelyan, E., Irwin, J.C., Huddleston, H.G., et al., In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration. J Assist Reprod Genet. 2018;35(5):757-770.
39. Mohamed, M. A., El-Sayed, M.A., Mokhtar, R.K., Torky, A.A.E. The value of using platelet rich plasma after hysteroscopic analysis of severe intrauterine adhesions (a randomized controlled trial). The Egyptian Journal of Hospital Medicine. 2018; 71: 2869-2874.
40. Puente Gonzalo, E., Alonso Pacheco, L., Vega Jiménez, A., Vitale, S.G., Raffone, A., Laganà, A.S., et al., Intrauterine infusion of platelet-rich plasma for severe Asherman syndrome: a cutting-edge approach. Updat Surg. 2021;73(6): 2355-2362.
41. Albazee, E., Al-Rshoud, F., Almahmoud, L., Al Omari, B., Alnifise, M., Baradwan, S., et al., Platelet-rich plasma for the management of intrauterine adhesions: A systematic review and meta-analysis of randomized controlled trials. J Gynecol Obstet Hum Reprod. 2022; 51(2):102-276.
42. Naghshineh, E., Rouholamin, S., Derakhshandeh, Z. Hormone therapy with or without platelet-rich plasma (PRP) for treatment Asherman syndrome; A randomized clinical trial. Adv Biomed Res. 2023;12-17.
43. Javaheri, A., Kianfar, K., Pourmasumi, S., Eftekhar, M. Platelet-rich plasma in the management of Asherman’s syndrome; An RCT. Int J Reprod Biomed 2020 Feb 27;18(2):113-120. Erratum in: Int J Reprod Biomed. 2021;19(4):392.
44. Aghajanova, L., Sundaram, V., Kao, C.N., Letourneau, J.M., Manvelyan, E., Cedars, M.I., et al., Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience. J Assist Reprod Genet. 2021;38(11):2955-2963.
Shilpa Dutta, Akash More, Priti Karadbhajne, Deepti Shrivastava. Contribution of platelet-rich plasma therapy in reproductive health science: A narrative review. Biomedicine: 2023; 43(3): 808-815